Page 56 - MemoriaEHD-Eng

RESEARCH GROUPS

á

ú
á
í

á
í

á
í
ñ

ó

Àé

í

PROGRAMME:
G0026
Portal Hypertension and

Cirrhosis

Group Members
Lead Researcher

STAFF MEMBERS
Bosch Genover, Jaume

Berzigotti, Annalisa
Esteva Espinosa, Clara
Contact:
Gallego Pinos, Javier
Hospital Clinico y Provincial de Barcelona. Garca Caldero, Hector

C/ Villarroel, 170. Barcelona. Garca Pras, Ester
E.mail: [email protected]
Mangone, Marco
Orts Salvador, Lara

Reverter Segura, Enrique
Saez Carceller, Rosa Mara Main lines of research

Vila Bellmunt, Sergi
Vilaseca Barcel, Marina
• Factors regulating hepatic microcirculation in normal and in cirrhosis, studies of
liver perfusion and isolated liver sinusoidal endothelial cells.

ASSOCIATED MEMBERS
• Post-transcriptional regulation of the activity of endothelial nitric oxide
Berzigotti, Annalisa
synthase(eNOS). Relevance in the treatment of portal hypertension.
Deulofeu Piguet, Ramon
Escorsell Maosa, ngels • Regulation of transcription of protective genes hepatic sinusoidal endotheli-

Fernndez Lobato, Mercedes um: relevance to the pathophysiology of portal hypertension in liver ex vivo
Garca Pagn, Juan Carlos preservation,and complications of cirrhosis.

Gilabert Sol, Rosa • Angiogenesis and portal hypertension: contribution to regulation of develop-

Gonzlez-Abraldes Iglesias, Juan ment of collateral circulation, hyperdynamic circulation and hepatic fibrogen- 13
Gracia Sancho, Jordi esis.
20
T
Hernndez Gea, Virginia • New non invasive evaluation of cirrhosis. R
Moncls Ribalaiga, Montserrat
PO
• Randomized clinical trials of new treatments for portal hypertension. E
L R
A
• Hepatic vascular disease. NU
N
• Prevention of decompensated cirrhosis. A
/
• Diagnostic biomarker discovery and response to treatment. HD
E
• Role of sinusoidal endothelium in ischemia-reperfusion injury liver. ER
IB
• Liver protection from external injury in healthy and cirrhotic livers.
C

56